Relacorilant plus Abraxane showed benefit without biomarker testing, potentially expanding treatment access for patients with platinum-resistant ovarian cancer.
Dr. Alexander B. Olawaiye
Advertisement
Director of gynecologic cancer research at Magee-Womens Hospital of UPMC.
Articles by Dr. Alexander B. Olawaiye
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
How to Become a Cancer Survivor and Transforming Patients into People
2
Immunotherapy Combo Shows Potential Progress in Some Pancreatic Cancers
3
New Combination Treatment Approach Studied in Pancreatic Cancer
4
NCCN Names Trodelvy a Preferred First-Line Treatment for Metastatic TNBC
5